HIV risk reduction and promotion of treatment adherence among transgender women

Development and assessment of a comprehensive and holistic intervention package to reduce HIV vulnerability and to maintain viral suppression among transgender women in India - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059191

Enrollment

800

Registered

2023-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Motivational interviewing-based counselling: Motivational interviewing-based counselling intervention will be provided by trained peer research counsellors, and will take place at the o

Eligibility

Inclusion criteria

Inclusion criteria: Self-identified adult transgender women (at least 18 years of age)

Exclusion criteria

Exclusion criteria: Those who self-identify as men who have sex with men

Design outcomes

Primary

Measure	Time frame
Consistent condom use with male partners (regular, casual, paying or paid) in the past month will be the key outcome indicator, irrespective of the HIV status of participants. Consistent condom use refers to reporting “always ? using condoms with male partners in the past month. For transgender women living with HIV, self-reported ART adherence (a proxy of viral suppression) is another key outcome indicator.Timepoint: Baseline and Post-intervention assessment (4th month)	—

Measure

Time frame

Consistent condom use with male partners (regular, casual, paying or paid) in the past month will be the key outcome indicator, irrespective of the HIV status of participants. Consistent condom use refers to reporting “always ? using condoms with male partners in the past month. For transgender women living with HIV, self-reported ART adherence (a proxy of viral suppression) is another key outcome indicator.Timepoint: Baseline and Post-intervention assessment (4th month)

—

Secondary

Measure	Time frame
Secondary outcomes will include depression, anxiety and problematic alcohol use. For Depression, percentage of those who report having moderate to severe depression using PHQ9 scoring guidelines. For Anxiety, percentage of those who report GAD2 score more than or equal to 3. For Problematic alcohol use, percentage of those who report concise AUDIT score more than or equal to 4.Timepoint: Baseline and Post-intervention assessment (4th month)	—

Measure

Time frame

Secondary outcomes will include depression, anxiety and problematic alcohol use. For Depression, percentage of those who report having moderate to severe depression using PHQ9 scoring guidelines. For Anxiety, percentage of those who report GAD2 score more than or equal to 3. For Problematic alcohol use, percentage of those who report concise AUDIT score more than or equal to 4.Timepoint: Baseline and Post-intervention assessment (4th month)

—

Countries

India

Contacts

Public ContactDr Seema Sahay PhD

Centre for Sexuality and Health Research and Policy (C-SHaRP)

cvenkatesan@c-sharp.in04442322262

Outcome results